HLL LIFECARE LIMITED
Company Summary
HLL Lifecare Limited (HLL), formerly known as Hindustan Latex Limited, acts as a manufacturer and markets the widest range of contraceptives. The range includes male condoms, female condoms, intra-ute…
🎙️ Company Audio Brief
💡 Quick Investor Summary
Key Highlights
Management Team
NEETA BOOCHRA
ADARSH PAL VIG
AJIT NANU
Show 42 past directors
ROLI SINGH
GEETA SHARMA
JAIDEEP KUMAR MISHRA
MANDEEP K BHANDARI
AYYAPPAN MADHAVAN NAIR
VENUGOPAL SANJEEVI
ARUN KUMAR PANDA
NAVED MASOOD
BABU THOMAS
ELAMTHURTHI ACHUTHAN SUBRAMANIAN
SANJIV KAPOOR
MOHANDAS KARUNAKARAN NAIR
NIKUNJA BIHARI DHAL
SIMHAMBHATLA KAMESWARA RAO
BRAJ KISHORE PRASAD
DHARMENDRA SINGH GANGWAR
PREETI PANT
SANJAY KUMAR
CHANDRASEKHARAN NAIR BHASKARAN NAIR
RAKESH PRASAD KHANDELWAL
MEENAKSHI SUNDARAN V VENKATESWARAN
ARUN SINGHAL
SURESH KUMAR KRISHNA PANICKER KALAMPU KATTU
RAKESH KUMAR VATS
SANJAY KUMAR SRIVASTAVA
SHAKUNTALA DOLEY GAMLIN
DHARITRI PANDA
GAUTAM GUHA
RAJIV RAMCHANDRA TAKRU
VIJAYA SRIVASTAVA
RAVINDER KUMAR JAIN
LAV AGARWAL
MANGLAVIL DAIVANAYAKOM SREEKUMAR
AARTI VIJ
SANTHANA KRISHNAN
ARADHANA JOHRI
RAJASEKAR TIMOTHY
VIJAYCHANDER REDDY PESARU
BEJI KAVUMKAL GEORGE
SREEKUMAR PRABHAKARAN NAIR
VEZHAPARAMBIL AMMUNNINAIR SASIDHARAN NAIR
GANESAN RAMASWAMI
IPO Tracker
Financial Statements
Profit & Loss Statement
| Line Item | FY 2025 |
|---|---|
| Net Revenue | ₹4469.51 Cr |
| Total Operating Cost | ₹1807.59 Cr |
| Operating Profit / (Loss) | ₹296.69 Cr |
| Other Income | ₹81.96 Cr |
| Depreciation | ₹42.02 Cr |
| Profit Before Tax | ₹312.42 Cr |
| Income Tax | ₹86.73 Cr |
| Profit After Tax (PAT) | ₹231.77 Cr |
Balance Sheet
| Line Item | FY 2025 |
|---|---|
| ASSETS | |
| Non-Current Investments | ₹30.98 Cr |
| Net Fixed Assets | ₹222.03 Cr |
| Total Non-Current Assets | ₹889.04 Cr |
| Cash & Bank Balances | ₹565.13 Cr |
| Trade Receivables | ₹2003.47 Cr |
| Total Current Assets | ₹3469.64 Cr |
| Total Assets | ₹4599.33 Cr |
| LIABILITIES & EQUITY | |
| Share Capital | ₹15.54 Cr |
| Reserves & Surplus | ₹1008.80 Cr |
| Total Equity | ₹1024.34 Cr |
| Long-Term Borrowings | ₹4.55 Cr |
| Deferred Tax (Net) | — |
| Total Non-Current Liabilities | ₹2695.55 Cr |
| Short-Term Borrowings | ₹219.00 Cr |
| Trade Payables | ₹0 |
| Total Current Liabilities | ₹879.44 Cr |
| Total Debt | ₹223.55 Cr |
Cash Flow Statement
| Line Item | FY 2025 |
|---|---|
| Operating Cash Flow | ₹20.96 Cr |
| Investing Cash Flow | -₹171.01 Cr |
| Financing Cash Flow | -₹45.38 Cr |
| Net Change in Cash | -₹195.43 Cr |
| Closing Cash Balance | -₹179.56 Cr |
Charts & Ratios
OCF vs PAT Ratio
Revenue & Profit Trend
Key Ratios
Debt & Equity
Cash Flow Breakdown
Key Ratios Table
Governance & Compliance
Capitalization Table
Peer Comparison
Industry: Healthcare — Medical Consumables
Sample Size: 30 peers (2025 data)
Target Company Ratios vs Industry Median
| Parameter | Company Value | Industry Median | Status |
|---|---|---|---|
| Revenue (₹ Cr) | 4469.51 | 234.26 | ▲ |
| Revenue Growth (%) | 19.82 | 7.75 | ▲ |
| EBITDA Margin (%) | 6.64 | 9.97 | ▼ |
| Net Margin (%) | 5.19 | 5.15 | ▲ |
| Return on Equity (%) | 22.63 | 11.95 | ▲ |
| Debt / Equity | 0.22 | 0.32 | ▲ |
| Inventory / Sales (Days) | 46.53 | 72.06 | ▲ |
| Debtors / Sales (Days) | 163.61 | 60.58 | ▼ |
| Payables / Sales (Days) | 0 | 33.66 | ▼ |
| Cash Conversion Cycle (Days) | 210.14 | 93.05 | ▼ |
| Sales / Net Fixed Assets | 20.13 | 3.99 | ▲ |
Closest Peers by Revenue
| Company Name | CIN | City | Revenue (₹) |
|---|---|---|---|
| HLL LIFECARE LIMITED | U25193KL1966GOI002621 | Thiruvananthapuram | 44,69,51,00,000 |
| PFIZER HEALTHCARE INDIA PRIVATE LIMITED | U24232TN2009PTC073563 | CHENNAI | 19,56,64,00,000 |
| SCHOTT POONAWALLA PRIVATE LIMITED | U26100MH1994PTC083938 | MUMBAI | 10,43,20,50,000 |
| HINDUSTAN SYRINGES AND MEDICAL DEVICES LIMITED | U74899DL1957PLC002834 | NEW DELHI | 8,40,02,65,000 |
| TERUMO PENPOL PRIVATE LIMITED | U33112KL1985PTC004531 | THIRUVANANTHAPURAM | 7,32,72,60,000 |